Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis

Affiliations

• ¹ Monash Children's Hospital, Clayton, Melbourne, Australia; Royal Children's Hospital, Parkville, Victoria, Australia.
• ² Italian Medicines Agency (AIFA), Rome, Italy.
• ³ Monash Children's Hospital, Clayton, Melbourne, Australia; Murdoch Childrens Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, Monash University, Clayton, Victoria, Australia.
• ⁴ The Brighton Collaboration Foundation, Basel, Switzerland.
• ⁵ Uppsala Monitoring Centre, Uppsala, Sweden.
• ⁶ Independent Consultant, Bethesda, MD, USA.
• ⁷ Department of Vaccines Control, National Agency for Medicines and Medical Devices, Tirana, Albania.
• ⁸ Pharmacovigilance Regional Centre of Lombardy, Italy.
• ⁹ Children's Mercy Hospital, Kansas City, MO, USA.
• ¹⁰ Ann & Robert H. Lurie Children's Hospital of Chicago, USA.
• ¹¹ Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
• ¹² Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera, San José, Costa Rica.
• ¹³ Independent Consultant Vaccinologist, Wakefield, RI, USA.
• ¹⁴ Boston Children's Hospital, Boston, USA.
• ¹⁵ CHU Sainte-Justine, Montreal, Canada.
• ¹⁶ Post Graduate Institute of Medical Education and Research (PGIMER) - Chandigarh, India.
• ¹⁷ The Brighton Collaboration Foundation, Basel, Switzerland; University of Basel Children's Hospital, Basel, Switzerland. Electronic address: contact@brightoncollaboration.org.
• ¹⁸ Monash Children's Hospital, Clayton, Melbourne, Australia; Murdoch Childrens Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, Monash University, Clayton, Victoria, Australia; Department of Paediatrics, Melbourne University, Parkville, Victoria, Australia.